Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
Go back to Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.82 -1.27 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.09 | 52 Week High | $77.12 | |||
| Open | $67.24 | 52 Week Low | $49.03 | |||
| Day High | $67.72 | P/E | 43.39 | |||
| Day Low | $66.58 | EPS | $1.54 | |||
| Volume | 4,825,368 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 72.72 -1.23 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.95 | 52 Week High | $13.18 | |||
| Open | $73.04 | 52 Week Low | $6.00 | |||
| Day High | $74.01 | P/E | N/A | |||
| Day Low | $72.26 | EPS | $-1.24 | |||
| Volume | 1,140,917 | |||||
